This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Stroke, Volume 56, Issue Suppl_1 , Page ATP170-ATP170, February 1, 2025. In stroke, it has been associated with infarct growth, hemorrhagic transformation, and poor outcomes. Conclusions:WMD burden did not have an independent association with 90-day functional outcomes or hemorrhagic transformation in the DEFUSE 3 cohort.
Stroke, Volume 56, Issue Suppl_1 , Page A13-A13, February 1, 2025. Conclusion:Intravenous Tirofiban as an adjunct to EVT may improve long-term functional outcomes in acute ischemic stroke patients due to PCTLs without significantly increasing the risk of hemorrhagic complications. 0.59], P=0.001).Conclusion:Intravenous
Stroke, Volume 56, Issue Suppl_1 , Page ATP242-ATP242, February 1, 2025. Background:Symptomatic intracranial hemorrhage (sICH) is the most dreaded complication after reperfusion therapy for acute ischemic stroke. The sICH risk for MT in the posterior circulation (RR: 7.48; 95%CI: 2.27-24.61) 2.07; P = 0.037). 1.03; P = 0.079).
Stroke, Volume 56, Issue Suppl_1 , Page ATP196-ATP196, February 1, 2025. Blood circulating CC-motif chemokine 11 (CCL11) increases in rodents and humans with age. To simulate aging with an increase of circulating CCL11 level, we intraperitoneally administered the CCL11 once every 4d for 1mo into the middle-aged mice.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP26-AWMP26, February 1, 2025. Introduction:Several pre-hospital scales predict ischemic stroke due to large vessel occlusion; however, these scales often fail to detect atypical endovascular thrombectomy (EVT) cases, including posterior circulation and distal vessel occlusion.
Stroke, Volume 56, Issue Suppl_1 , Page A133-A133, February 1, 2025. Introduction:Moyamoya is a progressive steno-occlusive cerebrovascular arteriopathy of bilateral anterior circulation. Twenty-three (34%) children had complete occlusion of bilateral anterior circulation without asymmetry at diagnosis.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP11-AWMP11, February 1, 2025. The AIS patients with LVO in the anterior circulation within 24 hours of symptom onset, baseline modified Rankin Scale (mRS) score 2, and Alberta Stroke Program Early CT Score (ASPECTS) score 6 were included.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP57-ATMP57, February 1, 2025. END was defined as an increase in total NIHSS4 or NIHSS2 for any item within 72 hours, without evidence of parenchymal hemorrhage. Patients who underwent endovascular treatment before END were excluded. 1.22,22.18] P=0.026).Conclusions:Higher
Stroke, Volume 56, Issue Suppl_1 , Page AWP253-AWP253, February 1, 2025. Background and Aims:Endovascular treatment (EVT) alone has been confirmed to be non-inferior to intravenous thrombolysis (IVT) followed with EVT in acute ischemic stroke (AIS) due to large-vessel occlusion of the anterior circulation.
Stroke, Volume 56, Issue Suppl_1 , Page ATP397-ATP397, February 1, 2025. Steep intracranial pressure (ICP) rise constitutes a hallmark of aneurysmal subarachnoid hemorrhage (SAH). In the brain parenchyma, we observed minimal infiltration of circulating immune cells, consistent with the effects of aneurysm rupture.
Stroke, Volume 56, Issue Suppl_1 , Page ATP19-ATP19, February 1, 2025. Safety outcomes were any intracerebral hemorrhage (ICH) and symptomatic ICH (sICH) at 24-36hrs. The primary efficacy outcome was good 3-month functional outcome, defined as a modified Rankin scale (mRS) 0-2.
Stroke, Volume 56, Issue Suppl_1 , Page ATP213-ATP213, February 1, 2025. While the association between DE and ischemic stroke is well established, the relationship with hemorrhagic stroke remains less clear. were male, mean age was 66, and 29.8% were white. 4.98, p=0.04).
Stroke, Volume 56, Issue 1 , Page 190-193, January 1, 2025. The prevalence of transient ischemic attacks, ischemic stroke, and hemorrhagic stroke did not differ between patients with aPL-positive and aPL-negative MMA.CONCLUSIONS:The prevalence of aPL in patients with MMA is comparable to that in non-MMA controls.
Stroke, Volume 56, Issue Suppl_1 , Page A160-A160, February 1, 2025. After tMCAO, plasma was obtained to measure circulating inflammatory factors using Multiplex and ELISA. The rate of hemorrhagic transformation (HT) was increased in both ePE-F1 males (100%) and females (62.5%) vs. NormP-F1s (male: 37.5%, female: 0%).
Stroke, Volume 56, Issue Suppl_1 , Page ATP175-ATP175, February 1, 2025. Anterior circulation AIS patients with large vessel occlusion were grouped based on the presence of a CBF core, defined as either 0 mL or greater than 0 mL, with a relative CBF less than 30% of normally perfused tissue on CT perfusion imaging.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP14-AWMP14, February 1, 2025. Introduction:Cerebral microbleeds (CMBs) are age-related manifestations of microangiopathies predisposing patients to hemorrhagic stroke (HS) and cognitive decline. Little work has currently been done to elucidate mechanisms in the pathophysiology of CMBs.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content